{"id":"W2121709831","doi":"10.1001/jama.2012.220","title":"Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy","year":2012,"lang":"en","type":"article","venue":"JAMA","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1214,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Agency for Healthcare Research and Quality; National Institutes of Health; Northern Illinois University; Sunovion; Canadian Institutes of Health Research; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; Eisai; Valeant Pharmaceuticals International; University of California, San Francisco; Acorda Therapeutics; Pfizer","keywords":"Medicine; Epilepsy; Randomized controlled trial; Epilepsy surgery; Quality of life (healthcare); Drug Resistant Epilepsy; Pediatrics; Clinical trial; Anterior temporal lobectomy; Surgery; Psychiatry; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}